What is the recommended treatment for a skin infection over the knee in a patient with no known allergies to penicillin or cephalosporins?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Skin Infection Over the Knee

For a skin infection over the knee in a patient without penicillin or cephalosporin allergies, treat with oral cephalexin 500 mg three to four times daily for 7-10 days, or alternatively, a penicillinase-resistant penicillin such as dicloxacillin 500 mg four times daily for the same duration. 1

First-Line Antibiotic Selection

Primary Treatment Options

  • Cephalexin (first-generation cephalosporin) is highly effective for streptococcal and staphylococcal skin infections, with cure rates of 90% or higher. 2
  • Penicillinase-resistant semisynthetic penicillins (dicloxacillin, flucloxacillin) or first-generation cephalosporins (cephalexin, cefazolin) should be selected for cellulitis and most skin infections. 1
  • These agents provide excellent coverage against Staphylococcus aureus and Streptococcus pyogenes, the two most common pathogens in skin and soft tissue infections. 1, 3

Dosing Regimens

  • Cephalexin: 500 mg orally three to four times daily for 7-10 days 1, 2
  • Dicloxacillin: 500 mg orally four times daily for 7-10 days 1
  • Flucloxacillin: 500 mg orally four times daily for 7-10 days 3

Alternative Options for Improved Compliance

Second-Generation Cephalosporins

  • Cefprozil offers equivalent clinical efficacy to cephalexin but with more convenient once or twice-daily dosing, which may improve patient compliance. 4
  • Cefadroxil and cefprozil can be given once daily with better tolerability profiles, though they are more expensive than cephalexin. 5

When to Consider Broader Coverage

  • If the infection does not respond to initial empirical therapy directed against S. aureus and S. pyogenes, obtain appropriate culture material to guide further treatment. 1
  • For infections associated with trauma, water contact, or animal/insect bites, broader antimicrobial coverage may be necessary. 1

Important Clinical Considerations

Duration of Therapy

  • Although antibiotics have been given for 10 days in most clinical trials, there is no evidence that this duration is more effective than a 7-day course. 5
  • The IDSA guidelines recommend 7-10 days for most uncomplicated skin infections. 1

Monitoring for Treatment Failure

  • Patients who do not respond to initial therapy should have cultures obtained to identify resistant organisms, including methicillin-resistant S. aureus (MRSA). 1
  • For community-acquired MRSA infections in otherwise healthy patients, clindamycin or trimethoprim-sulfamethoxazole are appropriate oral alternatives. 3, 5

Common Pitfalls to Avoid

  • Do not use cephalexin for infections involving the auricle (ear cartilage), as it lacks adequate Pseudomonas aeruginosa coverage. 6
  • Avoid using vancomycin, teicoplanin, or daptomycin for erysipeloid infections, as Erysipelothrix rhusiopathiae is resistant to these agents. 1
  • Ensure the infection is not necrotizing fasciitis or gas gangrene, which require immediate surgical intervention and different antimicrobial regimens (clindamycin plus penicillin). 1

When Parenteral Therapy Is Needed

  • For severe infections requiring intravenous therapy, ceftriaxone 1 g every 12 hours offers the advantage of once-daily dosing and may be suitable for outpatient treatment. 5
  • Cefazolin 1 g every 8 hours or ampicillin-sulbactam 1.5-3.0 g every 6 hours are also effective parenteral options. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical trials of cefprozil for treatment of skin and skin-structure infections: review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Guideline

Cephalexin for Auricle Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.